Ebola: Towards establishing a holistic approach to achieve effective management and control 1Muhammed Afolabi, 1Anna Roca, 1Kalifa Bojang, 2Egeruan Imoukhuede,

Slides:



Advertisements
Similar presentations
1 Regional Review and Appraisal of the Madrid International Plan of Action on Ageing (MIPAA) Ms. Noeleen Heyzer Under Secretary-General and Executive Secretary.
Advertisements

Track C on prevention issues Recognised Priority technical areas are ITNs, malaria in pregnancy, vector control, including use of DDT epidemics and complex.
EVD is a preventable but often fatal viral infection An EVD outbreak is affecting countries in West Africa where disease control resources are very limited.
EBOLA OUTBREAK 2014 There has never been an outbreak this size and severity.
Ebola Virus Disease Crisis in Western Africa Dr Marcos Espinal Director, Communicable Diseases and Health Analysis Washington DC, 24 September 2014.
Defining what the problem is Framing a research question FETP India.
Health Line of Business Revised Health Domains January 26, 2005 Outcomes / Domains have been revised.
CBER Regulatory Laboratory Planning & Preparedness for SARS-related Biologics Products Kathryn M. Carbone MD Associate Director for Research, Acting, Center.
Regional initiative to sustain country achievement SEAR Krongthong Thimasarn Regional Adviser, Malaria World Health Organization Regional Office for South-
Departmental Perspectives on Viral Hepatitis
BC Injury Prevention Strategy Working Paper for Discussion.
Introduction to Basic Science Emily L. Lowe, Ph.D. Microbiology, Immunology and Molecular Genetics UCLA.
Protect critical information with a smart information-based-risk management strategy. Prepared by: Firas Mohamed Taher.
January 27, th BVDV Symposium –BVDV Variability: Impact on Virulence, Host Range, and Control Bovine Viral Diarrhea Virus (BVDV) Research Needs.
Department of Health and Human Services Where do we go from here? RADM Dushanka V. Kleinman Assistant Surgeon General Chief Dental Officer, United States.
Established in late 1999 Scientific/clinical resources Ethics committees Regulatory body TT
Ebola Epidemic in Coastal West Africa – Overall Situation Report given at Caritas Internationalis Briefing Meeting 05 November 2014 Dr and Deacon Timothy.
Health Security and Emergencies Ebola Response 13 October 2014.
1 California Public Health Preparedness: Lessons from Seven Jurisdictions R. Burciaga Valdez, PhD June 8, 2004.
Crosswalk of Public Health Accreditation and the Public Health Code of Ethics Highlighted items relate to the Water Supply case studied discussed in the.
Local Public Health System Assessment using the NPHPSP Local Instrument Essential Service 5 Develop Policies and Plans that Support Individual and Community.
Strategy and Policy Cohesion: “The One Health Agenda: will it deliver” Elizabeth J. Phillips, MD, FRCPC,FRACP, FACTM Professor & Director, Centre for Clinical.
XVII INTERNATIONAL AIDS CONFERENCE PANCAP Satellite Meeting Hon Douglas Slater, Minister of Health, St. Vincent and the Grenadines.
A PRESENTATION BY: DETTA MOHAMAD ALNAAL JAMES BURGESS BUROOJ MUSHTAQ ANIMAN RANDHAWA Assignment 2: Ebola.
Establishing a Global Vaccine Development Fund Peter Hale The Foundation for Vaccine Research Washington, DC Consultation on Financing of R&D Preparedness.
History, culture and social norms: implications for Ebola drug and vaccine clinical trials in affected region Morenike Folayan and Bridget Haire, Aminu.
NVAC Influenza Working Group Vaccine Research, Development and Production.
Public Health Options for Implementing Vaccine Recommendations: A Framework for State Decision Making Donald Williamson, M.D. National Vaccine Advisory.
Framing a research question Chitra Grace A Scientist- C (PGDHE) NIE, Chennai RM Workshop for ICMR Scientists 01/11/2011.
One Health Meeting in the African Region, Libreville, Gabon, November 2012 Zoonotic Diseases in the African Region Dr. Benido Impouma EPR Regional.
RESEARCH FOR HEALTH RESEARCH AGENDA Gilbert Kokwaro, PhD Consortium for National Health Research.
Steps for the Integration of Traditional Medicine in the National Health Care Delivery System 18 TH ICASA Special Session on Traditional Medicine 1 st.
Trends and dynamics of HPAI - epidemiological and animal health risks Technical Meeting on HPAI and Human H5N1 Infection Rome, Italy, June 27-29, 2007.
Managing Pandemics Health. Health: Managing Pandemics OUTLINE What is a pandemic? Long term disease management: Malaria Sudden pandemic outbreaks: Ebola.
Dual Use Research of Concern
Response to the Yellow Fever Outbreak in the WHO African Region: What has been done? Dr Ambrose Talisuna, WHO-Regional Office for Africa-AFRO Brazzaville-Congo.
IAS Satellite Session 25th July 2017 Daniel Were, PhD
Ladies and gentlemen, On behalf of my country, the Republic of Côte d’Ivoire, I want to tell you how very pleased I am to be part of this high-level meeting,
HEALTH PROMOTION.
ROTAVIRUS COMMON, SEVERE, DEVASTATING, PREVENTABLE
Call for Action & International Initiative
Training structure EFFO Ebola Safety and good quality work
WASH and Cholera Preparedness to Response-
Infections and Environmental Interactions: Who is Responsible?
Descriptive Epidemiology
COMBINATION PREVENTION
Luann Drolc Fortune, PhD Saybrook University October 25, 2016
Non-ARV Based Interventions to Combat HIV/AIDS: New Insights and Initiatives Yves Lévy Inserm, VRI.
This is an archived document.
ISARIC – INTERNATIONAL SEVERE ACUTE RESPIRATORY INFECTION CONSORTIUM
Lecture 9: PHC As a Strategy For HP Dr J. Sitali
Ebola Virus Disease (EVD) WHAT IS IT?
World Health Organization
Anna Roca, PhD, Muhammed O
Content Public Health Emergencies Ebola Virus Disease: DRC
Advancing South-South Cooperation for Effective Implementation of
Content Public Health Emergencies Ebola Virus Disease: DRC
World Health Organization
Epidemiological Modeling to Guide Efficacy Study Design Evaluating Vaccines to Prevent Emerging Diseases An Vandebosch, PhD Joint Statistical meetings,
Strategy and Policy Cohesion: “The One Health Agenda: will it deliver”
The Role of NICs in Influenza Surveillance
Factors that affect disease dynamics and outbreaks
Angela L. Rasmussen, Michael G. Katze  Cell Host & Microbe 
Concepts of Nursing NUR 212
Amanda Rojek, MBBS, Prof Peter Horby, FRCP, Dr Jake Dunning, MRCP 
World Health Organization
Ebinformatics: Ebola fuzzy informatics systems on the diagnosis, prediction and recommendation of appropriate treatments for Ebola virus disease (EVD)
Introduction to Basic Research Methods
Assessment of Member States‘ 2nd River Basin Management Plans
National one Health Strategy( )
Presentation transcript:

Ebola: Towards establishing a holistic approach to achieve effective management and control 1Muhammed Afolabi, 1Anna Roca, 1Kalifa Bojang, 2Egeruan Imoukhuede, 1Umberto D’Alessandro, 1,3 Beate Kampmann 1Medical Research Council Unit, Fajara, The Gambia.2 The Jenner Institute, University of Oxford, United Kingdom, 3 Imperial College, London, United Kingdom. Introduction Model for potential strategies for holistic management Hypothesis of Ebola virus transmission at the human-animal interface Methods The current Ebola outbreak in West Africa has already caused substantial mortality and dire human and economic consequences Represents an alarming public health threat in the region and beyond Precise factors that result in an Ebola virus outbreak are less understood The effect of environmental changes on the Ebola outbreak in West Africa and disease dynamic is also unclear Broad examination of the complex and interwoven ecology and socio-economic factors may improve understanding on the current and future trends of EVD Comprehensive search of available current evidence on the Ebola virus, its disease pathogenesis, risk factors, dynamics of transmission, and epidemic control Experiential learning during emergency preparedness planning for EVD documented Evidence analyzed and a model for holistic management developed Priority areas of future research identified Findings Knowledge of the virus transmission and its transmission dynamics is still evolving Need for prioritized use of experimental drugs in the face of limited supply Changing dogma to accelerate development of vaccines and therapeutics Removing obstacles to accelerate the pace of Ebola vaccine and treatment trials Strengthening health systems and enforcing safe burial practices Area of future research: identification of surrogate markers for tracing bodily fluids, host immune mechanism in viral shedding, correlates of protection, effect of genetic modification on the virus, appropriate risk communication strategies, development of more effective contact tracing strategies Conclusions Epidemic curves in humans and animals at the human-animal interface Socio-cultural factors are the critical determinants for the success and failure of the control efforts Integration of research with capacity development of HCPs will facilitate the discovery, development, manufacture and delivery of quality, easy to use, affordable interventions and technologies for effective management and control Multi-pronged holistic approach appears to be more pragmatic in addressing the Ebola epidemic Bibliography Roca A, Afolabi MO, Saidu Y, Kampmann B. Ebola: A holistic approach is required to achieve effective management and control. Journal of Allergy and Clinical Immunology.2015;135:856-67 Geographical distribution of outbreaks in Africa